Medical Imaging Markets, Volume V: Molecular Imaging

Table of Contents

Chapter One: Executive Summary

• 1.1 Molecular Basis of Cell Function
• 1.2 Driving Healthcare
• 1.3 Two Components
• 1.4 Key Modalities
• 1.5 World Market Summary
• 1.5.1 Market Drivers and Challenges
• 1.5.2 Growth Analysis
• 1.6 Methodology

Chapter Two: Introduction

• 2.1 Background and Definitions
  • 2.1.1 Nuclear Medicine
  • 2.1.2 Imaging Agents and Traditional Anatomic Modalities
• 2.2 New Direction for Medicine
• 2.3 Modalities and Applications
  • 2.3.1 Nuclear Medicine
  • 2.3.1.1 Positron Emission Tomography (PET)
  • 2.3.1.2 Single Photon Emission Computed Tomography (SPECT) and Gamma Cameras
  • 2.3.2 Computed Tomography (CT)
  • 2.3.3 Magnetic Resonance Imaging (MRI)
  • 2.3.4 Ultrasound
  • 2.3.5 Fusion Imaging
  • 2.3.5.1 PET/CT
  • 2.3.5.2 SPECT/CT
  • 2.3.6 Optical Imaging, Near Infrared (NIR)
• 2.4 Drivers
• 2.5 Issues and Challenges
  • 2.5.1 Imaging Agent Delivery and Observation
  • 2.5.2 SPECT/CT and Targeted Imaging
  • 2.5.3 Optical Technology
  • 2.5.4 Application-Specific Controversies

Chapter Three: Promising Research

• 3.1 PET Targets Alzheimer' s Disease
• 3.2 Rubidium-Based PET
• 3.3 PET Diagnoses Pancreas Defects
• 3.4 Hyper-Cest MRI
• 3.5 Molecular Breast Imaging
• 3.6 Drug Abuse
• 3.7 Radiotracers and Drug Addiction
• 3.8 Whole-Body PET
• 3.9 PET/CT for Ovarian Cancer
• 3.10 SPECT for Lower Back Pain
• 3.11 Contrast-Enhanced Ultrasound
• 3.12 Preclinical Drug Research

Chapter Four: Markets

• 4.1 Overview
• 4.2 Procedures
• 4.3 Market Forecasts
  • 4.3.1 PET
  • 4.3.2 SPECT-Gamma Camera Systems
  • 4.3.3 Molecular Magnetic Resonance Imaging (MRI)
  • 4.3.4 Molecular Computed Tomography (CT)
  • 4.3.5 Ultrasound
  • 4.3.6 Fusion Imaging
  • 4.3.7 Optical Imaging

Chapter Five: Corporate Profiles

• 5.1 Agilent Technologies
• 5.2 Bioscan
• 5.3 Capintec Inc.
• 5.4 Digirad Corp
• 5.5 Gamma Medica Inc
• 5.6 GE Healthcare
• 5.7 Hitachi Medical Systems America Inc.
• 5.8 IS2 Medical Systems
• 5.9 MIR Preclinical Services
• 5.10 OptoSonics Inc.
• 5.11 Philips Medical Systems
• 5.12 Positron Corp.
• 5.12 Positron Corp.
• 5.13 Siemens Medical Solutions
• 5.14 Spectrum Dynamics Ltd.
• 5.15 Toshiba America Medical Systems
• 5.16 UltraSPECT Ltd.
• 5.17 VisEn Medical Inc.
• 5.18 Zecotek Medical Systems

Chapter One: Executive Summary

• Exhibit 1 Market Summary: World Market for Molecular Imaging 2007-2011

Chapter Two: Introduction

• Exhibit 2: Key Liquid Radionuclides

Chapter Four: Markets

• Exhibit 3: Worldwide Distribution of SPECT Procedures by Specialty 2006
• Exhibit 4: U.S. Distribution of SPECT Procedures by Specialty 2006
• Exhibit 5: Worldwide Distribution of PET Procedures by Specialty 2006
• Exhibit 6: U.S. Distribution of PET Procedures by Specialty 2006
• Exhibit 7: Worldwide Geographic Distribution of Molecular CT Procedures by Region (U.S., Europe, ROW) 2006
• Exhibit 8: Worldwide Geographic Distribution of Molecular MRI Procedures by Region (U.S., Europe, ROW) 2006
• Exhibit 9: World Medical Market for PET Systems Dollar Volume 2007-2011
• Exhibit 10: U.S. Medical Market for PET Systems Dollar Volume 2007-2011
• Exhibit 11: World Medical Market for PET Systems Unit Sales 2007-2011
• Exhibit 12: U.S. Medical Market for PET Systems Unit Sales 2007-2011
• Exhibit 13: World Medical PET Systems Estimated Installed Base by Region (U.S. vs Non-U.S.) 2006
• Exhibit 14: World Medical Market for SPECT Systems Dollar Volume 2007-2011
• Exhibit 15: U.S. Medical Market for SPECT Systems Dollar Volume 2007-2011
• Exhibit 16: World Medical Market for SPECT Systems Unit Sales 2007-2011
• Exhibit 17: U.S. Medical Market for SPECT Systems Unit Sales 2007-2011
• Exhibit 18: World Medical SPECT Systems Estimated Installed Base by Region (U.S. vs Non-U.S.) 2006
• Exhibit 19: World Medical Market for Molecular MRI Systems Dollar Volume 2007-2011
• Exhibit 20: U.S. Medical Market for Molecular MRI Systems Dollar Volume 2007-2011
• Exhibit 21: World Medical Market for Molecular CT Systems Dollar Volume 2007-2011
• Exhibit 22: U.S. Medical Market for Molecular CT Systems Dollar Volume 2007-2011
• Exhibit 23: World Medical Market for Molecular Ultrasound Systems Dollar Volume 2007-2011
• Exhibit 24: U.S. Medical Market for Molecular Ultrasound Systems Dollar Volume 2007-2011
• Exhibit 25: World Medical Market for Molecular PET/CT 2007-2011
• Exhibit 26: U.S. Medical Market for Molecular PET/CT 2007-2011
• Exhibit 27: World Medical Market for Molecular SPECT/CT 2007-2011
• Exhibit 28: U.S. Medical Market for Molecular SPECT/CT 2007-2011
• Exhibit 29: World Market for Molecular Imaging by Modality (PET, SPECT, CT, MRI, Ultrasound, PET/CT) 2007, 2009, 2011